Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 44451 - 44475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Fulvestrant	Approved Investigational	MYBL1	4603	downregulated	fulvestrant results in decreased expression of MYBL1 mRNA	8q13.1	A21106
Fulvestrant	Approved Investigational	MYC	4609	downregulated	fulvestrant results in decreased expression of MYC mRNA	8q24.21	A21102 A22731
Fulvestrant	Approved Investigational	NARS	4677	downregulated	fulvestrant results in decreased expression of NARS mRNA	18q21.31	A20479
Fulvestrant	Approved Investigational	NCAPH	23397	downregulated	fulvestrant results in decreased expression of NCAPH mRNA	2q11.2	A20479
Fulvestrant	Approved Investigational	NCL	4691	downregulated	fulvestrant results in decreased expression of NCL mRNA	2q37.1	A20479
Fulvestrant	Approved Investigational	NDC80	10403	downregulated	fulvestrant results in decreased expression of NDC80 mRNA	18p11.32	A22729
Fulvestrant	Approved Investigational	NEK2	4751	downregulated	fulvestrant results in decreased expression of NEK2 mRNA	1q32.3	A22729
Fulvestrant	Approved Investigational	NFKBIA	4792	downregulated	fulvestrant results in decreased expression of NFKBIA mRNA	14q13.2	A21168
Fulvestrant	Approved Investigational	NME1	4830	downregulated	fulvestrant results in decreased expression of NME1 mRNA	17q21.33	A22729
Fulvestrant	Approved Investigational	NMRK1	54981	downregulated	fulvestrant results in decreased expression of NMRK1 mRNA	9q21.13	A21106
Fulvestrant	Approved Investigational	NOV	4856	upregulated	fulvestrant results in increased expression of NOV mRNA	8q24.12	A21102 A20493
Fulvestrant	Approved Investigational	NPM1	4869	downregulated	fulvestrant results in decreased expression of NPM1 mRNA	5q35.1	A20479
Fulvestrant	Approved Investigational	NR4A1	3164	upregulated	fulvestrant results in increased expression of NR4A1 mRNA	12q13.13	A20479
Fulvestrant	Approved Investigational	NUS1	116150	downregulated	fulvestrant results in decreased expression of NUS1 mRNA	6q22.1	A20479
Fulvestrant	Approved Investigational	OLFM1	10439	downregulated	fulvestrant results in decreased expression of OLFM1 mRNA	9q34.3	A21106
Fulvestrant	Approved Investigational	PAX5	5079	upregulated	fulvestrant results in increased expression of PAX5 mRNA	9p13.2	A20482
Fulvestrant	Approved Investigational	PCLAF	9768	downregulated	fulvestrant results in decreased expression of PCLAF mRNA	15q22.31	A20479
Fulvestrant	Approved Investigational	PCNA	5111	downregulated	fulvestrant results in decreased expression of PCNA mRNA	20p12.3	A21102 A21116 A22729
Fulvestrant	Approved Investigational	PDZK1	5174	downregulated	fulvestrant results in decreased expression of PDZK1 mRNA	1q21.1	A21106
Fulvestrant	Approved Investigational	PGR	5241	downregulated	fulvestrant results in decreased expression of PGR mRNA	11q22.1	A21128 A21102 A21158 A22732 A21106
Fulvestrant	Approved Investigational	PIK3R3	8503	upregulated	fulvestrant results in increased expression of PIK3R3 mRNA	1p34.1	A21106
Fulvestrant	Approved Investigational	PIM1	5292	upregulated	fulvestrant results in increased expression of PIM1 mRNA	6p21.2	A21168
Fulvestrant	Approved Investigational	PLAUR	5329	downregulated	fulvestrant results in decreased expression of PLAUR mRNA	19q13	A21106
Fulvestrant	Approved Investigational	PLEKHF2	79666	upregulated	fulvestrant results in increased expression of PLEKHF2 mRNA	8q22.1	A21106
Fulvestrant	Approved Investigational	POLR2B	5431	downregulated	fulvestrant results in decreased expression of POLR2B mRNA	4q12	A20479

Displaying entries 44451 - 44475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability